Rigel Pharmaceuticals (RIGL) Other financing activities (2018 - 2025)

Rigel Pharmaceuticals' Other financing activities history runs 8 years deep, the most recent figure standing at $4.3 million for Q3 2025.

• In Q3 2025, Other financing activities rose 2603.16% year-over-year to $4.3 million; the TTM figure through Sep 2025 stood at $6.6 million (up 573.91% YoY), while the FY2024 annual figure was $2.0 million, up 87.23% from the prior year.
• Other financing activities was $4.3 million for Q3 2025 at Rigel Pharmaceuticals, up from $418000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.3 million in Q3 2025 to a low of $1000.0 in Q1 2023.
• Historically, Other financing activities has averaged $852941.2 across 5 years, with a median of $486000.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Other financing activities tumbled 99.89% in 2023, then jumped 8800.0% in 2024.
• A 5-year view of Other financing activities shows it stood at $1.1 million in 2021, then sank by 44.79% to $599000.0 in 2022, then fell by 18.86% to $486000.0 in 2023, then surged by 201.44% to $1.5 million in 2024, then surged by 191.54% to $4.3 million in 2025.
• The last three Other financing activities figures came in at $4.3 million (Q3 2025), $418000.0 (Q2 2025), and $484000.0 (Q1 2025), per Business Quant data.